 | • レポートコード：MRC2Q12-19321 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ペランパネルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ペランパネルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ペランパネルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ペランパネルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのペランパネルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のペランパネルの売上および2028年までの予測に焦点を当てています。 ペランパネルのグローバル主要企業には、Intas Pharma、Clinigen Group、Eisai、Alkaloida Chemical、Teva Pharma、ELPEN、CDMD、Qingfeng Pharma、Healthniceなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペランパネル市場は、タイプとアプリケーションによって区分されます。世界のペランパネル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 2Mg、4Mg、6Mg、10Mg 【アプリケーション別セグメント】 限局性発作、強直間代発作 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペランパネル製品概要 - タイプ別市場（2Mg、4Mg、6Mg、10Mg） - アプリケーション別市場（限局性発作、強直間代発作） - 調査の目的 ・エグゼクティブサマリー - 世界のペランパネル販売量予測2017-2028 - 世界のペランパネル売上予測2017-2028 - ペランパネルの地域別販売量 - ペランパネルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペランパネル販売量 - 主要メーカー別ペランパネル売上 - 主要メーカー別ペランパネル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（2Mg、4Mg、6Mg、10Mg） - ペランパネルのタイプ別販売量 - ペランパネルのタイプ別売上 - ペランパネルのタイプ別価格 ・アプリケーション別市場規模（限局性発作、強直間代発作） - ペランパネルのアプリケーション別販売量 - ペランパネルのアプリケーション別売上 - ペランパネルのアプリケーション別価格 ・北米市場 - 北米のペランパネル市場規模（タイプ別、アプリケーション別） - 主要国別のペランパネル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペランパネル市場規模（タイプ別、アプリケーション別） - 主要国別のペランパネル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペランパネル市場規模（タイプ別、アプリケーション別） - 主要国別のペランパネル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペランパネル市場規模（タイプ別、アプリケーション別） - 主要国別のペランパネル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペランパネル市場規模（タイプ別、アプリケーション別） - 主要国別のペランパネル市場規模（トルコ、サウジアラビア） ・企業情報 Intas Pharma、Clinigen Group、Eisai、Alkaloida Chemical、Teva Pharma、ELPEN、CDMD、Qingfeng Pharma、Healthnice ・産業チェーン及び販売チャネル分析 - ペランパネルの産業チェーン分析 - ペランパネルの原材料 - ペランパネルの生産プロセス - ペランパネルの販売及びマーケティング - ペランパネルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペランパネルの産業動向 - ペランパネルのマーケットドライバー - ペランパネルの課題 - ペランパネルの阻害要因 ・主な調査結果 |
Perampanel is a prescription medication used for the treatment of partial-onset and tonic-clonic seizures
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Perampanel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Perampanel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Perampanel is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Perampanel include Intas Pharma, Clinigen Group, Eisai, Alkaloida Chemical, Teva Pharma, ELPEN, CDMD, Qingfeng Pharma and Healthnice, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Perampanel manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Perampanel market. Further, it explains the major drivers and regional dynamics of the global Perampanel market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Intas Pharma
Clinigen Group
Eisai
Alkaloida Chemical
Teva Pharma
ELPEN
CDMD
Qingfeng Pharma
Healthnice
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage strength and by application segments based on sales, price, and value for the period 2017-2028.
Perampanel Segment by Dosage Strength
2Mg
4Mg
6Mg
10Mg
Perampanel Segment by Application
Localized Seizures
Tonic-Clonic Seizures
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Perampanel market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Perampanel, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Perampanel, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Perampanel, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Perampanel sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Perampanel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Perampanel sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Intas Pharma, Clinigen Group, Eisai, Alkaloida Chemical, Teva Pharma, ELPEN, CDMD, Qingfeng Pharma and Healthnice, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Perampanel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Perampanel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Perampanel sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Perampanel Product Introduction
1.2 Market by Dosage Strength
1.2.1 Global Perampanel Market Size Growth Rate by Dosage Strength, 2017 VS 2021 VS 2028
1.2.2 2Mg
1.2.3 4Mg
1.2.4 6Mg
1.2.5 10Mg
1.3 Market by Application
1.3.1 Global Perampanel Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Localized Seizures
1.3.3 Tonic-Clonic Seizures
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Perampanel Sales Estimates and Forecasts 2017-2028
2.2 Global Perampanel Revenue Estimates and Forecasts 2017-2028
2.3 Global Perampanel Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Perampanel Sales by Region
2.4.1 Global Perampanel Sales by Region (2017-2022)
2.4.2 Global Sales Perampanel by Region (2023-2028)
2.5 Global Perampanel Revenue by Region
2.5.1 Global Perampanel Revenue by Region (2017-2022)
2.5.2 Global Perampanel Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Perampanel Sales by Manufacturers
3.1.1 Global Top Perampanel Manufacturers by Sales (2017-2022)
3.1.2 Global Perampanel Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Perampanel in 2021
3.2 Global Perampanel Revenue by Manufacturers
3.2.1 Global Perampanel Revenue by Manufacturers (2017-2022)
3.2.2 Global Perampanel Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Perampanel Revenue in 2021
3.3 Global Perampanel Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Perampanel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Perampanel Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Strength
4.1 Global Perampanel Sales by Dosage Strength
4.1.1 Global Perampanel Historical Sales by Dosage Strength (2017-2022)
4.1.2 Global Perampanel Forecasted Sales by Dosage Strength (2023-2028)
4.1.3 Global Perampanel Sales Market Share by Dosage Strength (2017-2028)
4.2 Global Perampanel Revenue by Dosage Strength
4.2.1 Global Perampanel Historical Revenue by Dosage Strength (2017-2022)
4.2.2 Global Perampanel Forecasted Revenue by Dosage Strength (2023-2028)
4.2.3 Global Perampanel Revenue Market Share by Dosage Strength (2017-2028)
4.3 Global Perampanel Price by Dosage Strength
4.3.1 Global Perampanel Price by Dosage Strength (2017-2022)
4.3.2 Global Perampanel Price Forecast by Dosage Strength (2023-2028)
5 Market Size by Application
5.1 Global Perampanel Sales by Application
5.1.1 Global Perampanel Historical Sales by Application (2017-2022)
5.1.2 Global Perampanel Forecasted Sales by Application (2023-2028)
5.1.3 Global Perampanel Sales Market Share by Application (2017-2028)
5.2 Global Perampanel Revenue by Application
5.2.1 Global Perampanel Historical Revenue by Application (2017-2022)
5.2.2 Global Perampanel Forecasted Revenue by Application (2023-2028)
5.2.3 Global Perampanel Revenue Market Share by Application (2017-2028)
5.3 Global Perampanel Price by Application
5.3.1 Global Perampanel Price by Application (2017-2022)
5.3.2 Global Perampanel Price Forecast by Application (2023-2028)
6 North America
6.1 North America Perampanel Market Size by Dosage Strength
6.1.1 North America Perampanel Sales by Dosage Strength (2017-2028)
6.1.2 North America Perampanel Revenue by Dosage Strength (2017-2028)
6.2 North America Perampanel Market Size by Application
6.2.1 North America Perampanel Sales by Application (2017-2028)
6.2.2 North America Perampanel Revenue by Application (2017-2028)
6.3 North America Perampanel Market Size by Country
6.3.1 North America Perampanel Sales by Country (2017-2028)
6.3.2 North America Perampanel Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Perampanel Market Size by Dosage Strength
7.1.1 Europe Perampanel Sales by Dosage Strength (2017-2028)
7.1.2 Europe Perampanel Revenue by Dosage Strength (2017-2028)
7.2 Europe Perampanel Market Size by Application
7.2.1 Europe Perampanel Sales by Application (2017-2028)
7.2.2 Europe Perampanel Revenue by Application (2017-2028)
7.3 Europe Perampanel Market Size by Country
7.3.1 Europe Perampanel Sales by Country (2017-2028)
7.3.2 Europe Perampanel Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Perampanel Market Size by Dosage Strength
8.1.1 Asia Pacific Perampanel Sales by Dosage Strength (2017-2028)
8.1.2 Asia Pacific Perampanel Revenue by Dosage Strength (2017-2028)
8.2 Asia Pacific Perampanel Market Size by Application
8.2.1 Asia Pacific Perampanel Sales by Application (2017-2028)
8.2.2 Asia Pacific Perampanel Revenue by Application (2017-2028)
8.3 Asia Pacific Perampanel Market Size by Region
8.3.1 Asia Pacific Perampanel Sales by Region (2017-2028)
8.3.2 Asia Pacific Perampanel Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Perampanel Market Size by Dosage Strength
9.1.1 Latin America Perampanel Sales by Dosage Strength (2017-2028)
9.1.2 Latin America Perampanel Revenue by Dosage Strength (2017-2028)
9.2 Latin America Perampanel Market Size by Application
9.2.1 Latin America Perampanel Sales by Application (2017-2028)
9.2.2 Latin America Perampanel Revenue by Application (2017-2028)
9.3 Latin America Perampanel Market Size by Country
9.3.1 Latin America Perampanel Sales by Country (2017-2028)
9.3.2 Latin America Perampanel Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Perampanel Market Size by Dosage Strength
10.1.1 Middle East and Africa Perampanel Sales by Dosage Strength (2017-2028)
10.1.2 Middle East and Africa Perampanel Revenue by Dosage Strength (2017-2028)
10.2 Middle East and Africa Perampanel Market Size by Application
10.2.1 Middle East and Africa Perampanel Sales by Application (2017-2028)
10.2.2 Middle East and Africa Perampanel Revenue by Application (2017-2028)
10.3 Middle East and Africa Perampanel Market Size by Country
10.3.1 Middle East and Africa Perampanel Sales by Country (2017-2028)
10.3.2 Middle East and Africa Perampanel Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Intas Pharma
11.1.1 Intas Pharma Corporation Information
11.1.2 Intas Pharma Overview
11.1.3 Intas Pharma Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Intas Pharma Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Intas Pharma Recent Developments
11.2 Clinigen Group
11.2.1 Clinigen Group Corporation Information
11.2.2 Clinigen Group Overview
11.2.3 Clinigen Group Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Clinigen Group Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Clinigen Group Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Overview
11.3.3 Eisai Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eisai Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Alkaloida Chemical
11.4.1 Alkaloida Chemical Corporation Information
11.4.2 Alkaloida Chemical Overview
11.4.3 Alkaloida Chemical Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Alkaloida Chemical Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Alkaloida Chemical Recent Developments
11.5 Teva Pharma
11.5.1 Teva Pharma Corporation Information
11.5.2 Teva Pharma Overview
11.5.3 Teva Pharma Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Pharma Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharma Recent Developments
11.6 ELPEN
11.6.1 ELPEN Corporation Information
11.6.2 ELPEN Overview
11.6.3 ELPEN Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 ELPEN Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ELPEN Recent Developments
11.7 CDMD
11.7.1 CDMD Corporation Information
11.7.2 CDMD Overview
11.7.3 CDMD Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 CDMD Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CDMD Recent Developments
11.8 Qingfeng Pharma
11.8.1 Qingfeng Pharma Corporation Information
11.8.2 Qingfeng Pharma Overview
11.8.3 Qingfeng Pharma Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Qingfeng Pharma Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qingfeng Pharma Recent Developments
11.9 Healthnice
11.9.1 Healthnice Corporation Information
11.9.2 Healthnice Overview
11.9.3 Healthnice Perampanel Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Healthnice Perampanel Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Healthnice Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Perampanel Industry Chain Analysis
12.2 Perampanel Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Perampanel Production Mode & Process
12.4 Perampanel Sales and Marketing
12.4.1 Perampanel Sales Channels
12.4.2 Perampanel Distributors
12.5 Perampanel Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Perampanel Industry Trends
13.2 Perampanel Market Drivers
13.3 Perampanel Market Challenges
13.4 Perampanel Market Restraints
14 Key Findings in The Global Perampanel Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer